Liabilities / Assets
12th percentile
Higher debt load relative to assets than 12% of similar nonprofits.
990 • Fiscal year 2020 • EIN 47-5552178
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
12th percentile
Higher debt load relative to assets than 12% of similar nonprofits.
Liabilities / Revenue
26th percentile
Higher debt load relative to revenue than 26% of similar nonprofits.
Net Margin
55th percentile
Higher net margin than 55% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
99th percentile
Faster asset growth than 99% of similar nonprofits.
Revenue Growth
6th percentile
Faster revenue growth than 6% of similar nonprofits.
Assets
Up$46,386,492
Up $38,598,945 (+496%) from 2019
Net Assets
Up$45,845,621
Up $38,305,209 (+508%) from 2019
Liabilities
Up$540,871
Up $293,736 (+119%) from 2019
Revenue
Down$3,595,434
Down $3,434,917 (-49%) from 2019
Expenses
Down$3,388,466
Down $2,243,842 (-40%) from 2019
Net Income
Down$206,968
Down $1,191,075 (-85%) from 2019
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To fundamentally advance neuroscience clinical care through novel treatment approaches that optimize brain health and quality of life, to train the next generation of neuroscientists and clinicians, and to educate patients and the community at large on vital neuroscience issues.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2020 • Form 990Summary only. Only limited summary data is available for this year.